This document discusses the structure and pathology of the oral cavity and esophagus. It begins by describing the general four-layer structure of the esophagus which includes the mucosa, submucosa, muscularis and serosa layers. It then provides more details on the histology and functions of each layer. The document goes on to describe common oral pathologies like aphthous ulcers, oral candidiasis, leukoplakia and erythroplakia. It also discusses salivary gland structures, diseases like Sjogren's syndrome, mucoceles, ranulas, sialolithiasis and various benign and malignant salivary gland tumors.
Barrett's esophagus is a condition in which the tissue lining the esophagus—the muscular tube that connects the mouth to the stomach—is replaced by tissue that is similar to the lining of the intestine. This process is called intestinal metaplasia.
No signs or symptoms are associated with Barrett's esophagus, but it is commonly found in people with gastroesophageal reflux disease (GERD). A small number of people with Barrett's esophagus develop a rare but often deadly type of cancer of the esophagus.
Barrett's esophagus affects about 1 percent1 of adults in the United States. The average age at diagnosis is 50, but determining when the problem started is usually difficult. Men develop Barrett's esophagus twice as often as women, and Caucasian men are affected more frequently than men of other races. Barrett's esophagus is uncommon in children.
The EsophagusThe esophagus carries food and liquids from the mouth to the stomach. The stomach slowly pumps the food and liquids into the intestine, which then absorbs needed nutrients. This process is automatic and people are usually not aware of it. People sometimes feel their esophagus when they swallow something too large, try to eat too quickly, or drink very hot or cold liquids.
Digestive tract.
The muscular layers of the esophagus are normally pinched together at both the upper and lower ends by muscles called sphincters. When a person swallows, the sphincters relax to allow food or drink to pass from the mouth into the stomach. The muscles then close rapidly to prevent the food or drink from leaking out of the stomach back into the esophagus and mouth.
NIDDK
Barrett's esophagus is a condition in which the tissue lining the esophagus—the muscular tube that connects the mouth to the stomach—is replaced by tissue that is similar to the lining of the intestine. This process is called intestinal metaplasia.
No signs or symptoms are associated with Barrett's esophagus, but it is commonly found in people with gastroesophageal reflux disease (GERD). A small number of people with Barrett's esophagus develop a rare but often deadly type of cancer of the esophagus.
Barrett's esophagus affects about 1 percent1 of adults in the United States. The average age at diagnosis is 50, but determining when the problem started is usually difficult. Men develop Barrett's esophagus twice as often as women, and Caucasian men are affected more frequently than men of other races. Barrett's esophagus is uncommon in children.
The EsophagusThe esophagus carries food and liquids from the mouth to the stomach. The stomach slowly pumps the food and liquids into the intestine, which then absorbs needed nutrients. This process is automatic and people are usually not aware of it. People sometimes feel their esophagus when they swallow something too large, try to eat too quickly, or drink very hot or cold liquids.
Digestive tract.
The muscular layers of the esophagus are normally pinched together at both the upper and lower ends by muscles called sphincters. When a person swallows, the sphincters relax to allow food or drink to pass from the mouth into the stomach. The muscles then close rapidly to prevent the food or drink from leaking out of the stomach back into the esophagus and mouth.
NIDDK
'Oral Potentially Malignant Disorders' includes a variety of lesions with risk of progression to malignancy. It is widely prevalent in the Indian population, and early diagnosis and management is the need of the hour.
Here's a discussion of the same with methods of early diagnosis of such lesions.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
3. General Structure
Mucosa (mucous membrane)
1. epithelium
2. lamina propria
3. muscularis mucosa
4. functions
a. barrier / protection
b. absorption
c. secretion
5. General Structure
Muscularis
1. two smooth muscle layers
a. inner circular
b. outer longitudinal
2. myenteric (Auerbach’s) plexus
3. function
a. mix
b. propel
7. Oral Cavity (e.g., cheek, lips)
A. Mucosa
1. Stratified squamous nonkeratinized epith.
2. lamina propria
B. Submucosa
1. Microscopic salivary (seromucous) glands
C. Muscularis
1. facial skeletal muscles
8. Aphthous ulcers ( Canker sores )
• Common
• Superficial ulcerations of the oral mucosa
• Affects 40% of population in the united states
• 1st two decades of life.
• Painful/recurrent/tend to prevalent within
certain families
• Lesions: single or multiple, shallow, hyperemic
ulcerations. Covered by a thin exudate & rimmed
a narrow zone of erythema.
9. Aphthous ulcers ( Canker sores)
• Inflammatory infiltrate of mononuclear cells,
if secondary bacterial infection, numerous
neutrophils.
• Lesions clear within a wk.
• Cause –obscure
• Treatment- symptomatic
10. Oral candidiasis( oral thrush )
• Candida- fungus is a normal inhabitant of the
oral cavity & cause mischief in individuals who
are diabetic, neutropenic, or
immunoincompetent ( AIDS) e.t.c
• Oral lesions: superficial, curdy, gray to white
inflammatory membrane composed of matted
organisms enmeshed in a fibrinosuppurative
exudate that can be readily scraped off to reveal
an underlying erythematous inflammatory base.
11. White plaques and ulcerations in the esophagus indicate
infection with
Candida
13. GMS stain shows characteristic
pseudohyphae and buds of Candida
14. Tumors & precancerous lesions
• Leukoplakia: means simply white plaque.
• Def: a white plaque on the oral mucous membrane
that cannot be removed by scraping & cannot be
classified clinically or microscopically as another
disease entity.
• D/D lichen planus, candidiasis
• Leukoplakic plaques range from benign epithelial
thickening to highly atypical lesions with dysplastic
changes that merge with carcinoma in situ.Thus,
leukoplakia is a clinical term; until it is proved
otherwise, it must be considered precancerous.
• 5-15% undergo transformation to cancer
16. Erythroplakia ( dysplastic leukoplakia)
• Lesions: red, velvety, eroded area within oral
cavity that usually remains level with or may
be slightly depressed in elation to the
surrounding mucosa.
• Epithelial changes are markedly atypical, with
higher risk of malignant transformation than
that with leukoplakia.
19. Leukoplakia & Erythroplakia
• Potentiating influences
Alcohol
ill-fitting dentures
Chronic exposure to persistent irritants.
HPV ( Human papilloma virus) ,serotype 16
have been identified in tobacco –related
lesions.
20. Morphology
• Leukoplakia occur any where in oral cavity
( buccal mucosa, floor of mouth, ventral
surface of tongue, hard palate).
• Solitary or multiple, white patches or plaques
with indistinct or sharply demarcated borders.
• Slightly thickened & smooth or wrinkled &
indurated.
• May be raised, corrugated, verrucous plaques.
21. Histology: Leukoplakia
• Hyperkeratosis overlying thickened acanthotic
but orderly mucosal epithelium to lesions with
dysplastic changes.
• The more dysplastic or anaplastic the lesion,
the more likely a subjacent inflammatory
infiltrate of lymphocytes & macrophages.
23. Histology: : erythroplakia
• Epithelial atypia is more marked
• Intense subepithelium inflammatory reaction
with vascular dilation accounts for the red
appearance of the lesion.
24. Squamous cell carcinoma
• 95% of cancers of oral cavity
• Others: adenocarcinoma ( of mucous gland
origin),melanomas, various cacarcinomas.
• Age: 50 to 70yrs
Pathogenesis:
• Use of tobacco & alcohol
• Nondrinking smokers = 2-fold to 4-fold
greater risk
25. Squamous cell carcinoma
• Drinking & smoking : 6-fold to 15-fold
• Chewing tobacco & buccal pouches.
• Use of marijuana
• Chewing of betel nuts & pan in India.
• HPV serotype 6,16 & 18 – identified in half of oral
carcinomas arising in waldeyer tonsillar ring & in
10%- 15% in tongue & other parts of oral cavity.
• Deletions of chromosome regions 18q, 10p, 8p,& 3p;
mutations in p53; &lification of the INT2 &
BCL1 oncogenes.
• protracted irritation
26. Morphology
• Site: floor of the mouth, tongue, hard palate & base
of tongue.
• Clinically, a well-defined, white plaque caused by
hyper- and parakeratosis
• Raised,firm,pearly plaques or as irregular,
roughened or verrucous areas of mucosal
thickening.
• As enlarges, create protruding masses or undergo
central necrosis, forming, au irregular, shaggy ulcer
rimmed by elevated ,firm, rolled borders.
28. Microscopy: SCC
• Begin as in situ lesions.
• Slowly to rapidly growing lesions.
• Infiltrate locally before they metastasize.
• Metastasis: mediastinal lymph nodes, lungs,
liver,& bones.
• 50% of tongue and 60% of floor of mouth SCC
are in nodes at diagnosis
• 30% five year survival for SCC of tongue and
floor of mouth
29. Microscopy: SCC
• Well- differentiated keratinizing neoplasms to
anaplastic.
• Gross - Types:
Ulcerative type :most frequent
Papillary or verrucous: soft & wart like growth
Nodular: firm, low growing submucosal nodule.
Scirrhous: infiltration into deeper structures.
33. Introduction
• Three major salivary glands- Parotid, submandibular,&
sublingual & innumerable minor salivary glands
distributed throughout mucosa of the oral cavity.
• Xerostomia: dry mouth
• Major feature of autoimmune disorder sjogren
syndrome( accompanied by dry eyes, enlargement of
salivary glands)
• A lack of salivary secretions may be a complication of
radiation therapy.
• Oral cavity:Dry mucosa or atrophy of paillae of tounge,
with fissuring & ulcerations
34. Sjogren’s Syndrome
• Immune-mediated destruction of the lacrimal
and salivary glands. (Primary form or sicca
syndrome)
• often occurring in association with rheumatoid
arthritis or another autoimmune disorder
( secondary form )
• Xerostomia( dry mouth) and keratoconjunctivitis
sicca ( dry eyes)
• Biopsy shows dense lymphoplasmacytic
inflammatory infiltrate with destruction of
glandular tissue
36. Gross appearance of Mikulicz’s disease of parotid gland. There is a combination of
solid areas resulting from infiltration by lymphocytes and small cystic formations
representing dilated ductal lumina.
39. Mucocele
• Common lesion
• Results from blockage or rupture of a salivary gland duct,
with consequent leakage of saliva into surrounding CT
stroma.
• Lower lip: result of trauma
• Toddlers, young adults, geriatric population ( as a result of
falling )
• Fluctuant swellings of the lower lip, have blue translucent
hue to them
• Complete excision of cyst with minor salivary gland lobule
of origin.
• Incomplete excision- recurrence.
43. Cystlike space tht is lined by inflammatory granulation tissue or by fibrous CT.
Cystic spaces are filled with mucin & inflammatory cells ( macrophages)
45. Ranula
• Ranula: Histologically identical to a mucocele
• Mucoceles that arise when the duct of
sublingual gland is damaged.
• Plunging ranula: extremely large ,when it
dissects its way through the CT stroma
connecting the two bellies of mylohyoid
muscle.
46.
47. Sialolithiasis with secondary chronic sialadenitis. A large stone is blocking a major
salivary duct. Common offenders: staph aureus & strep. Viridans )
53. Salivary Gland
• < 2% of tumours in humans
• Parotid gland : 65-80% ( 15-30% malignant)
• Submandibular gland -10%
• Minor SG ( sublingual)- Remainder
• Salivary gland tumor being malignant is more or
less inversely proportional to the size of the gland
• Usually occur in adults
• Female predominance(warthin’s tumor in M>F)
• 5% occur in children ( younger than age 16yrs)
• Benign – 5th -7th decade
• Malignant – later
54. Pleomorphic Adenoma (mixed tumor of
salivary gland)
• Most common salivary gland tumor
• Most often arises in superficial parotid
• Circumscribed,glistening, myxoid lesion
• Histologically shows heterogeneous mix of ducts,
acini, and sheets of cells in a myxoid or chondroid
stroma
• Complete resection is necessary to prevent
recurrence (10% recurrence rate)
• Low percentage show malignant areas
55. Pleomorphic Adenoma (mixed tumor
of salivary gland)
• Most common salivary gland tumor
• Most often arises in superficial parotid
• Parotid gland : 60%
• Submandibular gland –less common
• Minor SG ( sublingual)- rare
• Derived from a mixture of ductal ( epithelial) & myoepithelial cells
& therefore show both epithelial & mesenchymal differentiation
• Reveal epithelial elements dispersed throughout a matrix along
with varying degrees of myxoid ,hyaline, chondroid & osseous
tissue.
• Radiation exposure increases the risk.
56. Pleomorphic Adenoma (mixed tumor
of salivary gland)
• Gross: rounded ,well –demarcated masses ( 6cm in greatest
dimension)
• Encapsulated
• In palate- capsule is not fully developed, expansile growth
produces tongue like protrusions into the surrounding gland.
• C/s gray-white with myxoid & blue translucent areas of
chondroid.
• Micriscopy:
64. Benign mixed tumor (left) with area of malignant transformation in the form of poorly
differentiated carcinoma (right).
65. Warthin’s Tumor/ adenolymphoma /
Papillary cystadenoma lymphomatosum
• Benign tumor of the parotid gland
• 2nd most common SG neoplasm.
• M>F
• 5th -7th decade
• 1o% -multifocal, 10% B/L
• Smokers : 8 times the risk than nonsmokers.
• Well-encapsulated green-brown mass with cleft-like
spaces on the cut surface
• Admixture of oncocytic epithelium and subjacent
lymphoid tissue
• 10% recurrence rate
66. Warthin’s Tumor
• Morphology:
• Gross: rounded to oval
• Encapsulated masses
• 2-5cm in dia
• c/s Pale gray surface punctuated by narrow
cystic or cleft like spaces filled with a
mucinous or serous secretions.
67. gross appearance of Warthin’s tumor of parotid gland. The presence of multiple large
cystic spaces is characteristic of this lesion.
69. Low-power appearance of Warthin’s tumor.
Spaces are lined by double layer of epi cells resting on a dense lymphoid
stroma, sometimes bearing germinal centers
Spaces narrowed by polypoid projections of the lymphoepithelial elements.
72. High-power view of the lining of one of the cysts of Warthin’s tumor.
The epithelium is tall and oxyphilic ( palisade of columnar cells having abundant finely
granular, eosinophilic cytoplasm) ,
with a discontinuous layer of small cells at the base(cuboidal to polygonal cells ).
The stroma beneath contains a monotonous lymphocytic infiltrate.
73. Mucoepidermoid carcinoma
• Composed of variable mixtures of Mucous,
squamous, and intermediate cells
• 15%- all SG neoplasms
• 60- 70% - parotid gland
• Common malignant tumor primary in SG
• Most common radiation induced neoplasm
74. Gross appearance of mucoepidermoid carcinoma.
solid, without cystic formations commonly seen in low-grade
lesions.
• Range: 8cm in dia
• Circumscribed
• Lack well- defined capsule
• Infiltrative at margins
• C/S pale-gray white, small
mucin containing cyst.
82. Acinic cell tumor
• Composed cells resembling serous cells of
salivary gland.
• Uncommon ( 2-3% of SG )
• Common- parotid than submandibular
• Minor SG ( rarely)
• Gross: Small, discrete lesions
• Recurrence : level of pleomorphism
• 10-15% - metastasize to lymphnodes.
83. Acinic cell carcinoma.
cells have an abundant cytoplasm filled with basophilic zymogen
granules.
Sheets, Microcystic, glandular, follicular or papillary
Few mitosis, little anaplasia